Sweden-based software-as-a-service (SaaS) solution that helps healthcare providers implement best practices for surgical care to improve patient outcomes, Encare raised EUR 1.5 million in recent financing. The company announced the fundraise on May 29, 2023. Existing shareholders, together with some new, through the Society network, provided the investment for the firm.
Purpose of financing for Encare
With the latest capital injection, the SaaS healthcare company Encare seeks to promote the continued expansion of its business operations.
It further seeks to invest in product development. Meanwhile, the company intends to enter into new international markets, such as the United States of America and further expand its reach.
In addition, the company aims to increase revenue by expanding sales to existing customers. It also plans to focus on acquiring new customers. Additionally, Encare will prioritise product development to cater to specific market needs. Currently, the healthcare company enjoys a strong market presence, serving more than 150 hospitals across the world. It further experienced remarkable growth of more than 30% in the last year.
What the company’s official has to add
Rasmus Waller, CEO of Encare, said, “Thanks to the continued support from our investors, we can continue our expansion and work towards our mission to positively impact the lives of millions of patients undergoing surgery worldwide. By supporting healthcare providers in implementing best practices in surgical care, Encare can contribute to reducing the number of preventable deaths and complications during surgery.”
About the company
Professor Olle Ljungqvist is the founder of the company launched in 2019. Encare is a Sweden-based healthtech company that develops a SaaS solution aiming to improve the outcome of surgery. Encare’s interactive, cloud-based solution enables healthcare providers to follow international treatment guidelines before, during, as well as after major surgical procedures. The solution provides guidance spanning across the entire patient care continuum, i.e., from initial diagnosis and preparation to surgery and rehabilitation.
The guidelines known as ERAS® (Enhanced Recovery After Surgery), providers are able to reduce complications, expedite patient recovery, and further shorten hospital stays.
The ERAS Society is a non-profit scientific organisation created to provide perioperative care protocols and enhance postoperative recovery via research, instruction, auditing, and the use of best practices. The guidelines provided are supported by scientific study and evidence.
Encare’s solution has the potential to prevent avoidable deaths and complications, resulting in significant cost savings for the global healthcare industry.
For more extensive analysis and Market Intelligence reports, feel free to approach us.
We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know
if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover
–what information you are looking for in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!